Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

The requested reference [b1f7a6e4f230db1e02e5fd1353224ca66c367e1d] no longer exists in our database. It has been replaced by the current reference: [114569aa129338f3fb4267b373f44cac317a0414]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study is designed as a randomized, double-blind, parallel-group study to evaluate the PK, safety, tolerability, immunogenicity, and PD of TUR03 compared to Soliris, when administered as a single IV infusion in healthy adult male participants.
Epistemonikos ID: 124c1be50da61306f092a3a1f2f2dc46c9ccaca6
First added on: Feb 19, 2024